Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Fluorouracil (5-FU)

3

XII.af Coronary vasospasm - Vasospastic angina

2
Last update : 20/04/2014
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil.
Case reports in oncological medicine 2020;2020;4151474 2020
5-Fluorouracil-Associated Coronary Vasospasm in a Patient With Metastatic Adenocarcinoma of the Esophagus.
American journal of therapeutics 2019;26;e664-e668 2019
5-fluorouracil and cardiotoxicity: a review.
Therapeutic advances in medical oncology 2018;10;1758835918780140 2018
Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
Bulletin du cancer 2006 Mar 01;93;E27-30 2006 Mar 01
Prinzmetal's angina during 5-fluorouracil chemotherapy.
The American journal of medicine 1987 Mar;82;566-8 1987 Mar

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies